These results, together with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the concept of focusing on ACKR3 as a novel strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-connected disorders. Morphine as well as https://theodorv345bqe5.wikicommunication.com/user